Abstract

BackgroundThe effectiveness of biologic disease modifying anti-rheumatic drugs (DMARDs) on clinical outcome in rheumatoid arthritis (RA) has been studied in several biologic DMARD registries. However, real life long term clinical...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call